Chicago, IL, January 8, 2013 – Monroe Capital LLC today announced the funding of a $46.5 million unitranche credit facility to support the recapitalization of Conisus, LLC by private equity sponsor, Webster Capital.
Based in Atlanta, GA, Conisus, LLC offers innovative, scientific-oriented promotional marketing and education solutions to a diverse group of biopharmaceutical companies to assist in the promotion and education of oncology drugs and therapies. The company is led by a seasoned management team with deep experience in oncology that spans medical education, global marketing, sales and clinical practice.
Monroe Credit Advisors LLC served as the exclusive syndication agent to Monroe Capital LLC.
About Monroe Capital
Monroe Capital LLC is a leading provider of senior and junior debt and equity co-investments to middle-market companies in the U.S. and Canada. Investment types include unitranche financings, cash flow and enterprise value based loans, acquisition facilities, mezzanine debt, second lien or last-out loans and equity co-investments. Monroe Capital prides itself on its flexible investment approach and its ability to close and fund transactions quickly. Monroe is committed to being a value-added and user-friendly partner to owners, senior management and private equity sponsors. To learn more about Monroe Capital LLC, visit www.monroecap.com
About Webster Capital
Founded in 2003, Webster Capital is a private equity partnership with over $200 million in capital under management which invests in healthcare services, branded consumer and business to business companies. Webster focuses on companies with EBITDA of between $3 million to $15 million and transaction values of less than $100 million. Webster Capital provides equity financing, expertise and a broad contact network for management buyouts and growth capital. For additional information on Webster Capital please visit www.webstercapital.com